At the news
? BEARISHIMPACT 6/10 6-K filed Nov 5, 2026 at 08:30 ET
Baird Medical received a Nasdaq deficiency notice for its bid price being below $1.00 for 30 consecutive business days, triggering a 180-day compliance period through May 3, 2027. The company also issued a statement acknowledging recent share price volatility but citing no material undisclosed reason. With a market cap of only $5M, the delisting risk is material.
- Nasdaq notified Baird Medical on November 2, 2026 that its bid price was below $1.00 for 30 consecutive business days, violating Listing Rule 5550(a)(2).
- The company has 180 calendar days, until May 3, 2027, to regain compliance by closing at $1.00 or above for 10 consecutive business days.
- If compliance is not achieved by May 3, 2027, Baird Medical may be eligible for an additional 180-day grace period or face delisting.
- The company issued a separate press release on November 4, 2026 stating it is not aware of any material development explaining the recent share price decline.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access